Geneva Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-89,179
| Closed | -$21.9M | – | 129 |
|
|
2022
Q3 | $21.9M | Sell |
89,179
-1,247
| -1% | -$306K | 0.51% | 75 |
|
|
2022
Q2 | $22.4M | Sell |
90,426
-812
| -0.9% | -$201K | 0.52% | 77 |
|
|
2022
Q1 | $30.2M | Sell |
91,238
-1,557
| -2% | -$516K | 0.58% | 72 |
|
|
2021
Q4 | $33.3M | Sell |
92,795
-3,255
| -3% | -$1.17M | 0.54% | 76 |
|
|
2021
Q3 | $31.3M | Sell |
96,050
-4,871
| -5% | -$1.59M | 0.53% | 79 |
|
|
2021
Q2 | $31.5M | Sell |
100,921
-3,662
| -4% | -$1.14M | 0.51% | 81 |
|
|
2021
Q1 | $33.3M | Sell |
104,583
-5,003
| -5% | -$1.59M | 0.57% | 74 |
|
|
2020
Q4 | $35.5M | Sell |
109,586
-12,363
| -10% | -$4.01M | 0.6% | 70 |
|
|
2020
Q3 | $33.8M | Sell |
121,949
-6,608
| -5% | -$1.83M | 0.7% | 65 |
|
|
2020
Q2 | $31.1M | Sell |
128,557
-2,302
| -2% | -$556K | 0.67% | 67 |
|
|
2020
Q1 | $19M | Buy |
+130,859
| New | +$19M | 0.54% | 76 |
|
|
2014
Q3 | $16.5M | Sell |
666,378
-11,638
| -2% | -$289K | 0.48% | 74 |
|
|
2014
Q2 | $17M | Buy |
678,016
+43,170
| +7% | +$1.09M | 0.42% | 76 |
|
|
2014
Q1 | $16.5M | Buy |
634,846
+79,513
| +14% | +$2.07M | 0.39% | 75 |
|
|
2013
Q4 | $14.9M | Buy |
555,333
+219,431
| +65% | +$5.87M | 0.34% | 85 |
|
|
2013
Q3 | $6.4M | Buy |
+335,902
| New | +$6.4M | 0.15% | 102 |
|